Jin Medical International Stock Z Score

ZJYL Stock   0.95  0.11  10.38%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out JIN MEDICAL Piotroski F Score and JIN MEDICAL Valuation analysis.
  
At this time, JIN MEDICAL's Issuance Of Capital Stock is quite stable compared to the past year. Capital Expenditure Coverage Ratio is expected to rise to 25.29 this year, although the value of Net Invested Capital will most likely fall to about 19.5 M. At this time, JIN MEDICAL's Depreciation And Amortization is quite stable compared to the past year. Selling General Administrative is expected to rise to about 2 M this year, although the value of Selling And Marketing Expenses will most likely fall to about 464.3 K.

JIN MEDICAL INTERNATIONAL Company Z Score Analysis

JIN MEDICAL's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

JIN Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for JIN MEDICAL is extremely important. It helps to project a fair market value of JIN Stock properly, considering its historical fundamentals such as Z Score. Since JIN MEDICAL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of JIN MEDICAL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of JIN MEDICAL's interrelated accounts and indicators.
0.980.84-0.44-0.540.89-0.87-0.360.92-0.361.00.78-0.84-0.6-0.830.990.790.980.97
0.980.93-0.41-0.70.96-0.88-0.510.9-0.520.980.88-0.84-0.69-0.920.980.890.941.0
0.840.93-0.25-0.90.98-0.77-0.660.78-0.760.850.98-0.76-0.82-0.960.840.990.80.93
-0.44-0.41-0.250.01-0.350.680.07-0.470.13-0.44-0.10.630.070.43-0.48-0.11-0.49-0.41
-0.54-0.7-0.90.01-0.840.550.87-0.590.91-0.56-0.90.580.840.87-0.54-0.93-0.48-0.7
0.890.960.98-0.35-0.84-0.81-0.670.85-0.690.90.93-0.82-0.85-0.980.890.950.850.96
-0.87-0.88-0.770.680.55-0.810.44-0.90.52-0.87-0.690.940.430.85-0.88-0.7-0.87-0.88
-0.36-0.51-0.660.070.87-0.670.44-0.50.78-0.38-0.640.480.760.74-0.37-0.7-0.24-0.52
0.920.90.78-0.47-0.590.85-0.9-0.5-0.50.910.7-0.95-0.61-0.850.880.740.910.89
-0.36-0.52-0.760.130.91-0.690.520.78-0.5-0.38-0.740.610.70.8-0.35-0.78-0.36-0.51
1.00.980.85-0.44-0.560.9-0.87-0.380.91-0.380.8-0.84-0.61-0.841.00.80.970.98
0.780.880.98-0.1-0.90.93-0.69-0.640.7-0.740.8-0.66-0.76-0.910.790.990.730.89
-0.84-0.84-0.760.630.58-0.820.940.48-0.950.61-0.84-0.660.560.87-0.82-0.7-0.87-0.83
-0.6-0.69-0.820.070.84-0.850.430.76-0.610.7-0.61-0.760.560.82-0.58-0.83-0.54-0.69
-0.83-0.92-0.960.430.87-0.980.850.74-0.850.8-0.84-0.910.870.82-0.83-0.93-0.8-0.92
0.990.980.84-0.48-0.540.89-0.88-0.370.88-0.351.00.79-0.82-0.58-0.830.780.960.98
0.790.890.99-0.11-0.930.95-0.7-0.70.74-0.780.80.99-0.7-0.83-0.930.780.740.89
0.980.940.8-0.49-0.480.85-0.87-0.240.91-0.360.970.73-0.87-0.54-0.80.960.740.93
0.971.00.93-0.41-0.70.96-0.88-0.520.89-0.510.980.89-0.83-0.69-0.920.980.890.93
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

As per the company's disclosures, JIN MEDICAL INTERNATIONAL has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

JIN Fundamentals

About JIN MEDICAL Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze JIN MEDICAL INTERNATIONAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL INTERNATIONAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out JIN MEDICAL Piotroski F Score and JIN MEDICAL Valuation analysis.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Earnings Share
0.02
Revenue Per Share
0.129
Quarterly Revenue Growth
0.03
Return On Assets
0.0403
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.